• 11177 Citations
  • 52 h-Index
1989 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
Mantle-Cell Lymphoma Medicine & Life Sciences
Multiple Myeloma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Dexamethasone Medicine & Life Sciences
Survival Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

Acalabrutinib for adults with mantle cell lymphoma

Jurczak, W., Długosz-Danecka, M. & Wang, L., Jan 1 2019, (Accepted/In press) In : Expert Review of Clinical Pharmacology.

Research output: Contribution to journalArticle

A phase II study of carfilzomib in the treatment of relapsed/refractory mantle cell lymphoma

Lee, H. J., Badillo, M., Romaguera, J. & Wang, L., Feb 1 2019, In : British Journal of Haematology. 184, 3, p. 460-462 3 p.

Research output: Contribution to journalLetter

Mantle-Cell Lymphoma
carfilzomib

Increase in survival for patients with mantle cell lymphoma in the era of novel agents in 1995–2013: Findings from Texas and national SEER areas

Fu, S., Wang, L., Li, R., Lairson, D. R., Zhao, B. & Du, X. L., Feb 1 2019, In : Cancer Epidemiology. 58, p. 89-97 9 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Epidemiology
Survival
Registries
Neoplasms
29 Citations

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Wang, L., Rule, S., Zinzani, P. L., Goy, A., Casasnovas, O., Smith, S. D., Damaj, G., Doorduijn, J., Lamy, T., Morschhauser, F., Panizo, C., Shah, B., Davies, A., Eek, R., Dupuis, J., Jacobsen, E., Kater, A. P., Le Gouill, S., Oberic, L., Robak, T. & 9 othersCovey, T., Dua, R., Hamdy, A., Huang, X., Izumi, R., Patel, P., Rothbaum, W., Slatter, J. G. & Jurczak, W., Feb 17 2018, In : The Lancet. 391, 10121, p. 659-667 9 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Therapeutics
Safety
acalabrutinib
Myalgia

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma

Wang, Y., Nowakowski, G. S., Wang, L. & Ansell, S. M., Apr 23 2018, In : Journal of Hematology and Oncology. 11, 1, 57.

Research output: Contribution to journalReview article

Hodgkin Disease
Programmed Cell Death 1 Receptor
Antibodies
Secondary Prevention
Radiotherapy